Yale University

Publications

Filters: Keyword is Metabolic Clearance Rate  [Clear All Filters]
2005
Smith, Patrick F., Robert Dicenzo, Alan Forrest, Mark Shelton, Gerald Friedland, Michael Para, Richard Pollard, Margaret Fischl, Robin DiFrancesco, and Gene D. Morse. "Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals." Clinical pharmacokinetics 44, no. 1 (2005): 99-109. Abstract
Chawarski, Marek C., David E. Moody, Juliana Pakes, Patrick G. O'Connor, and Richard S. Schottenfeld. "Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms." Journal of substance abuse treatment 29, no. 4 (2005): 307-12. Abstract
2006
McCance-Katz, Elinore F., Petrie M. Rainey, Patrick Smith, Gene D. Morse, Gerald Friedland, Beth Boyarsky, Marc Gourevitch, and Peter Jatlow. "Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 15, no. 1 (2006): 23-34. Abstract
2010
Bruce, Robert Douglas, Frederick L. Altice, David E. Moody, Gene D. Morse, Laurie Andrews, Shen-Nan Lin, Wenfang B. Fang, Qing Ma, and Gerald H. Friedland. "Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir." Journal of acquired immune deficiency syndromes (1999) 54, no. 5 (2010): 511-4. Abstract